| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ad87c2f33a30df644248bdfea647f35 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-734 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2008-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a119f1ee033911a6f54565943b7e6bcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91ba39273fc099a1d85d8254f95a3333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eac8b2675e74a25945ebdc8d8d872452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd215266067c1a16dc467c685686c3a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dc4c28df855a9cd5f53e0b225d56dd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be441611c9a8e77ab80e16eecbd2879d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_533d5e06e8f9d32e4694b5caed03cec6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00778615eb5c3ed30da7938f3df9b1d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8568c4c9e13110ceb8ac2c835f67378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a5a6d6ffae3d4ab72b0d77186b27c3 |
| publicationDate |
2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011142844-A1 |
| titleOfInvention |
Anti-Extended Type I Glycosphingolipid Antibody, Derivatives Thereof And Use |
| abstract |
Human antibodies and antigen-binding portions of those antibodies that specifically bind extended Type I chain glycosphingolipids are provided. |
| priorityDate |
2008-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |